Insider Selling: Serina Therapeutics (NYSEAMERICAN:SER) Insider Sells 6,500 Shares of Stock

Serina Therapeutics, Inc. (NYSEAMERICAN:SER - Get Free Report) insider Randall Moreadith sold 6,500 shares of the stock in a transaction that occurred on Wednesday, January 28th. The shares were sold at an average price of $3.57, for a total value of $23,205.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Randall Moreadith also recently made the following trade(s):

  • On Thursday, January 22nd, Randall Moreadith sold 2,500 shares of Serina Therapeutics stock. The stock was sold at an average price of $2.95, for a total value of $7,375.00.
  • On Wednesday, January 21st, Randall Moreadith sold 2,000 shares of Serina Therapeutics stock. The stock was sold at an average price of $3.00, for a total value of $6,000.00.

Serina Therapeutics Price Performance

SER stock opened at $3.54 on Friday. Serina Therapeutics, Inc. has a fifty-two week low of $1.71 and a fifty-two week high of $7.92.

About Serina Therapeutics

(Get Free Report)

Serina Therapeutics, Inc, a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc was founded in 2006 and is based in Huntsville, Alabama.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Serina Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Serina Therapeutics and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles